MDGL: Madrigal Pharmaceuticals, Inc. Common Stock Company Profile & Statistics

About

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.

Info & Links

CEO

William J. Sibold

Headquarters

200 BARR HARBOR DRIVE, SUITE 200
WEST CONSHOHOCKEN, PA 19428, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

528

Madrigal Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

7.35B

Enterprise Value

7.37B

Enterprise Value/EBITDA(ttm)

-14.88

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

9.85

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

72.21%

Operating Margin(ttm)

Profit Margin(ttm)

-316.93%

Return on Equity(ttm)

-71.78%

Return on Invested Capital(ttm)

-49.64%

Return on Assets(ttm)

-53.25%

Income Statement

Revenue(ttm)

180.13M

Revenue Per Share(ttm)

8.16

Gross Profit(ttm)

173.90M

EBITDA(ttm)³

-495.09M

Net Income Available to Common(ttm)

-465.89M

Diluted EPS(ttm)

-25.08

Share Statistics

Beta (5Y Monthly)

-0.38

52-Week Change

63.67%

S&P 500 52-Week Change

10.97%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

22.08M

Dividend Yield

0.00%

Float⁴

16.84M

% Held by Insiders

22.80%

% Held by Institutions

98.50%

Balance Sheet

Total Cash(mrq)

931.25M

Total Cash Per Share(mrq)

42.18

Total Debt(mrq)

117.57M

Total Debt/Equity(mrq)

15.58%

Current Ratio(mrq)

6.10%

Quick Ratio(mrq)

5.93%

Book Value Per Share(mrq)

34.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-21.42

Free Cash Flow(ytd)

-457.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MDGL

Madrigal Pharmaceuticals, Inc. Common Stock

Madrigal Pharmaceuticals, Inc. Common Stock Profile